A global study of over 88,000 adults reveals that poor sleep habits—like going to bed inconsistently or having disrupted ...

A groundbreaking international study, recently published in Health Data Science, analyzed objective sleep data from 88,461 adults in the UK Biobank and found significant associations between sleep ...

In the largest study of its kind, researchers linked irregular sleep patterns to elevated risk for 172 diseases.

Apnimed, a pharmaceutical company developing oral therapies for obstructive sleep apnea (OSA) and related conditions, announced positive topline results from its second pivotal Phase 3 trial of AD109 ...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 27 years, gives his ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

ResMed will release its fourth-quarter earnings next week, and analysts anticipate a double-digit bottom-line growth.

The global Sleep Apnea Devices Market, valued at US$6.4 billion in 2024 stood at US$6.9 billion in 2025 and is projected to advance at a resilient ...

When Trump unveiled his aggressive tariff plan in April 2024, markets tanked as investors feared a full-blown trade war. But ...

With ASX reporting season kicking off next month, Australian investors may be wondering which ASX healthcare stocks to buy.